| 174.93 -0.14 (-0.08%) | 04-10 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 206.88  |
1-year : | 241.64 |
| Resists | First : | 177.13 |
Second : | 206.88 |
| Pivot price | 169.22 |
|||
| Supports | First : | 166.67 |
Second : | 160.21 |
| MAs | MA(5) : | 172.72 |
MA(20) : | 168.5 |
| MA(100) : | 164.99 |
MA(250) : | 160.11 |
|
| MACD | MACD : | 0.5 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 89.3 |
D(3) : | 85 |
| RSI | RSI(14): 59.7 |
|||
| 52-week | High : | 183.89 | Low : | 138.31 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ BCpC ] has closed below upper band by 11.8%. Bollinger Bands are 14% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 175.05 - 175.94 | 175.94 - 176.63 |
| Low: | 171.07 - 172.02 | 172.02 - 172.75 |
| Close: | 173.39 - 174.98 | 174.98 - 176.21 |
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
Sat, 11 Apr 2026
Montanaro Asset Management Ltd's Balchem Corp(BCPC) Holding History - GuruFocus
Thu, 09 Apr 2026
Balchem Corporation (BCPC) Stock Forecasts - Yahoo Finance
Wed, 08 Apr 2026
Price-Driven Insight from (BCPC) for Rule-Based Strategy - Stock Traders Daily
Tue, 07 Apr 2026
Is It Too Late To Consider Balchem (BCPC) After Recent Valuation Signals? - Yahoo Finance
Tue, 07 Apr 2026
Balchem (BCPC) CAO details stock, option and restricted share positions - Stock Titan
Tue, 07 Apr 2026
BCPC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Basic Materials
|
|
|
Industry:
Chemicals - Specialty
|
|
| Shares Out | 32 (M) |
| Shares Float | 32 (M) |
| Held by Insiders | 0.4 (%) |
| Held by Institutions | 92 (%) |
| Shares Short | 396 (K) |
| Shares Short P.Month | 279 (K) |
| EPS | 4.76 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 39.22 |
| Profit Margin | 14.9 % |
| Operating Margin | 19.8 % |
| Return on Assets (ttm) | 8 % |
| Return on Equity (ttm) | 12.8 % |
| Qtrly Rev. Growth | 9.8 % |
| Gross Profit (p.s.) | 11.57 |
| Sales Per Share | 32.46 |
| EBITDA (p.s.) | 7.95 |
| Qtrly Earnings Growth | 17.2 % |
| Operating Cash Flow | 217 (M) |
| Levered Free Cash Flow | 136 (M) |
| PE Ratio | 36.74 |
| PEG Ratio | 0 |
| Price to Book value | 4.45 |
| Price to Sales | 5.38 |
| Price to Cash Flow | 25.86 |
| Dividend | 0.95 |
| Forward Dividend | 0 |
| Dividend Yield | 0.5% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|